FibroGen (FGEN) Tops Q4 EPS by 35c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of $0.18, $0.35 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $22.09 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• HSBC Downgrades Stellantis NV (STLA:IM) (STLA) to Reduce
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform